老年慢性阻塞性肺疾病的药物治疗

被引：2

作者：

陈小东

机构：

[1] 复旦大学附属华山医院呼吸科

来源：

世界临床药物 | 2004年 / 09期

关键词：

慢性阻塞性肺疾病; COPD; 老年病; 药物治疗;

D O I：

暂无

中图分类号：

R563.9 [其他];

学科分类号：

摘要：

慢性阻塞性肺疾病(COPD)是老年人最常见的慢性呼吸系统疾病,严重危害老年人健康,并已成为老年人致残的主要病因之一。抗感染药、平喘药和糖皮质激素等药物在COPD的治疗中占重要地位。考虑到老年COPD患者不同的病理生理特征以及老年人脏器功能特点,建议采取个体化治疗方案,以减少药物的不良反应,提高药物疗效。开发新的更安全有效的COPD治疗药物仍是今后的研究方向,并有可能防止或阻抑COPD的发生和发展,降低COPD在老年人中的发病率,延长老年人生命。

引用

页码：536 / 539

页数：4

共 7 条

[1]

Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Sin DD,Tu JV. American Journal of Respiratory and Critical Care Medicine . 2001

[2]

Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. McNicholas WT,Calverley PM,Lee A,et al. European Respiratory Journal . 2004

[3]

Management of chronic obstructive pulmonary disease in the elderly. Antoneili Incalzi R. Aging Clinical and Experimental Research . 2004

[4]

PDE4 inhibitors in COPD-amore selective approach to treatment. Vignola AM. Respiratory Medicine . 2004

[5]

Combination of ICSs and LABAs should be used in the management of patients with COPD-the con argument. Road J. Canadian Respiratory Journal . 2004

[6]

Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient. Murphy TF,Sethi S. Drugs and Aging . 2002

[7]

Chronic obstructive pulmonary disease (COPD) in elderly subjects: Impact on functional status and quality of life. Peruzza S,Sergi G,Vianello A,et al. Respiratory Medicine . 2003

← 1 →